MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

20 Jan 2023 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1843.60
Dr. Reddys Labs. 1151.45
Cipla 1353.45
Lupin 2067.00
Zydus Lifesciences 1111.45
View more..